Ser16 prevails over Thr17 phospholamban phosphorylation in the β- adrenergic regulation of ardiac relaxation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Kuschel, Meike ^a,b   Karczewski, Peter ^a   Hempel, Petra ^a   Schlegel, Wolfgang Peter ^a   Krause, Ernst Georg ^a   Bartel, Sabine ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Adenosine 3',5' cyclic monophosphate dependent protein kinase; Calcium calmodulin dependent protein kinase; Cross signaling adenosine 3',5' cyclic monophosphate calcium; Intact rat heart; Relaxation

Indexed keywords

CALCIUM CHANNEL; ISOPRENALINE; NIFEDIPINE; PHOSPHOLAMBAN; RYANODINE; VERAPAMIL; ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIMYCIN; CALCIUM; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL L TYPE; CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN-DEPENDENT PROTEIN KINASE II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IONOPHORE; PROTEIN KINASE (CALCIUM,CALMODULIN); SERINE; THREONINE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; HEART INNERVATION; HEART MUSCLE RELAXATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; HEART CONTRACTION; HEART MUSCLE; METABOLISM; ORGAN CULTURE TECHNIQUE; PHOSPHORYLATION; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIMYCIN; CALCIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; IONOPHORES; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; RATS; RECEPTORS, ADRENERGIC, BETA; SARCOPLASMIC RETICULUM; SERINE; THREONINE;

EID: 0033125604     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.5.h1625     Document Type: Article

References (45)

1. 2+-independent in intact beating hearts. FEBS Lett. 409: 131-136, 1997.
2. Baltas, L., P. Karczewski, and E.-G. Krause. The cardiac sarcoplasmic reticulum phospholamban kinase is a distinct δ-CaM kinase isozyme. FEBS Lett. 373: 71-75, 1995.
3. Bassani, R. A., A. Mattiazzi, and D. M. Bers. CaM kinase II is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H703-H712, 1995.
4. Bilezikjian, L. M., E. G. Kranias, J. D. Potter, and A. Schwartz. Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase. Circ. Res. 49: 1356-1362, 1981.
5. 2+ sparks. Cell Calcium 20: 129-140, 1996.
6. Drago, G. A., and J. Colyer. Phosphorylation site-specific antibodies to cardiac phospholamban. J. Biol. Chem. 269: 25073-25077, 1994.
7. 2+ channel requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19: 185-196, 1997.
8. Gilman, A. G. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc. Natl. Acad. Sci. USA 67: 305-312, 1970.
9. 2+-uptake in cardiac sarcoplasmic reticulum. Eur. J. Biochem. 176: 535-541, 1988.
10. 17 of phospholamban in rat cardiac muscle. Pflügers Arch. 434: 475-483, 1997.
11. 2+ transient in rat hearts is independent of phospholamban phosphorylation. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H695-H706, 1997.
12. 2+-pump stimulation. Biochem. J. 316: 201-207, 1996.
13. Kadambi, V. J., S. Ponniah, J. M. Harrer, B. D. Hoit, G. W. Dorn, R. A. Walsh, and E. G. Kranias. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97: 533-539, 1996.
14. Karczewski, P., S. Bartel, and E.-G. Krause. Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem. J. 266: 115-122, 1990.
15. 2+/calmodulin-dependent protein kinase of cardiac sarcoplasmic reticulum. Basic Res. Cardiol. 92, Suppl. 1: 37-43, 1997.
16. Katz, A. M. Calcium channel diversity in the cardiovascular system. J. Am. Coll. Cardiol. 8: 522-529, 1996.
17. Levy, M. N. Neural control of the heart: sympathetic-vagal interactions. In: Cardiovascular System Dynamics, edited by J. Baan, A. Noodergraaf, and J. Raines. Cambridge, MA: MIT Press, 1978, p. 365-370.
18. Li, L., G. Chu, E. G. Kranias, and D. M. Bers. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMK II effects. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H1335-H1347, 1998.
19. 2+-calmodulin-dependent mechanisms. J. Biol. Chem. 260: 4516-4520, 1985.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
21. Luo, W., I. L. Grupp, J. M. Harrer, S. Ponniah, G. Grupp, J. J. Duffy, T. Doetschman, and E. G. Kranias. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ. Res. 75: 401-409, 1994.
22. Luo, W., C. Guoxiang, Y. Sato, Z. Zhou, V. J. Kadambi, and E. G. Kranias. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J. Biol. Chem. 273: 4734-4739, 1998.
23. Luo, W., Y. Sato, V. J. Kadambi, and E. G. Kranias. Reintroduction of wild-type and mutant phospholamban into phospholamban-deficient hearts reverses enhanced contractility (Abstract). Circulation 94, Suppl. I: 1087, 1996.
24. Mao, C., and A. Guidotti. Simultaneous isolation of adenosine 3′,5′-cyclic monophosphate (cAMP) and guanosine 3′,5′-cyclic monophosphate (cGMP) in small tissue samples. Anal. Biochem. 59: 63-68, 1974.
25. Masaki, H., Y. Sato, W. Luo, E. G. Kranias, and A. Yatani. Phospholamban deficiency alters inactivation kinetics of L-type Ca channels in mouse ventricular myocytes. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H606-H612, 1997.
26. 2+ transport in permeabilized cardiac myocytes. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H812-H820, 1994.
27. Mundiña, C., L. Vittone, M. Ortales, G. Chiappe de Cingolani, and A. Mattiazzi. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J. Biol. Chem. 271: 33561-33567, 1996.
28. Murray, K. J., P. J. England, J. A. Lynham, D. Mills, and M. Reeves. Protein kinase measurement of cAMP-dependent protein kinase ratio in hearts by use of a synthetic peptide. Biochem. Soc. Trans. 16: 355-361, 1988.
29. Neumann, J., R. C. Gupta, W. Schmitz, H. Scholz, A. C. Nairn, and A. M. Watanabe. Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ. Res. 69: 1450-1457, 1991.
30. Rapundalo, S. T., R. J. Solaro, and E. G. Kranias. Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins. Circ. Res. 64: 104-111, 1989.
31. 2+ release channel. Am. J. Physiol. 253 (Cell Physiol. 22): C364-C368, 1987.
32. 2+ channel and ryanodine receptors in cardiac myocytes. Proc. Natl. Acad. Sci. USA 92: 121-125, 1995.
33. Simmerman, H. K. B., J. H. Collins, J. L. Theiber, A. D. Wegener, and L. R. Jones. Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261: 13333-13341, 1986.
34. Sulakhe, P. V., and T. X. Vo. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization. Mol. Cell. Biochem. 149-150: 103-126, 1995.
35. Sutko, J. L., and J. T. Willerson. Ryanodine alterations of the contractile state of rat ventricular myocardium: comparison with dog, cat, and rabbit ventricular tissues. Circ. Res. 46: 332-343, 1980.
36. Swank, R. T., and K. D. Munkres. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulphate. Anal. Biochem. 39: 462-477, 1971
37. Talosi, L., I. Edes, and E. G. Kranias. Intracellular mechanisms mediating reversal of β-adrenergic stimulation in intact beating hearts. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H791-H797, 1993.
38. Tanaka, H., and K. Shigenobu. Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J. Mol. Cell. Cardiol. 21: 1305-1313, 1989.
39. Trautwein, W., and J. Hescheler. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu. Rev. Physiol. 52: 257-274, 1990.
40. Vittone, L., C. Mundiña, G. Chiappe de Cingolani, and A. Mattiazzi. cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H318-H325, 1990.
41. Vittone, L. C., G. Mundiña, G. Chiappe de Cingolani, and A. Mattiazzi. Role of phospholamban phosphorylation on the relaxant effect of β-adrenergic agonists. Mol. Cell. Biochem. 124: 33-42, 1993.
42. Vittone, L. C., G. Mundiña-Weilenmann, M. Said, and A. Mattiazzi. Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart. J. Biol. Chem. 273: 9804-9811, 1998.
43. Wegener, A. D., H. K. B. Simmermann, J. P. Lindemann, and L. R. Jones. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation. J. Biol. Chem. 264: 11469-11474, 1989.
44. 2+/calmodulin-dependent kinase II activity by membrane voltage and calcium influx. Proc. Natl. Acad. Sci. USA 91: 9659-9663, 1994.
45. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 268: 8394-8397, 1993.